Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen

Allergology International

Volumn 64, Issue 1, 2015, Pages 54-59

  Yamanaka, Kei ichi ^a   Shah, Said Ahmad ^a   Sakaida, Hiroshi ^a   Yamagiwa, Akisa ^a   Masuda, Sawako ^b   Mizutani, Hitoshi ^a   Takeuchi, Kazuhiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

Author keywords

Immunotherapy; Interleukin 10; Mononuclear cells; Regulatory T cells; T cells

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 10; PLACEBO; POLLEN EXTRACT; ALLERGEN; BIOLOGICAL MARKER; IMMUNOGLOBULIN E;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOLOGICAL PARAMETERS; IMMUNOPROPHYLAXIS; JAPANESE CEDAR; MALE; MONOCYTE; MONONUCLEAR CELL; MULTICENTER STUDY; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; SUBLINGUAL IMMUNOTHERAPY; ADOLESCENT; ADVERSE EFFECTS; ASYMPTOMATIC DISEASE; CLINICAL TRIAL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; POST EXPOSURE PROPHYLAXIS; PROGNOSIS; RHINITIS, ALLERGIC, SEASONAL; T LYMPHOCYTE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ALLERGENS; ASYMPTOMATIC DISEASES; B-LYMPHOCYTES; BIOMARKERS; CRYPTOMERIA; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-10; MALE; MIDDLE AGED; MONOCYTES; POLLEN; POST-EXPOSURE PROPHYLAXIS; PROGNOSIS; RHINITIS, ALLERGIC, SEASONAL; SUBLINGUAL IMMUNOTHERAPY; T-LYMPHOCYTES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84952325019     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2014.07.001     Document Type: Article

References (16)

1. 1 Okuda, M., Ishikawa, T., [Practical guideline for the management of allergic rhinitis in Japan-perennial rhinitis and pollinosis-2009 edition]. 2008, Life Science, Tokyo (in Japanese).
2. 2 Yonekura, S., Okamoto, Y., Horiguchi, S., Sakurai, D., Chazono, H., Hanazawa, T., et al. Effects of aging on the natural history of seasonal allergic rhinitis in middle-aged subjects in South Chiba, Japan. Int Arch Allergy Immunol 157 (2012), 73–80.
3. 3 Okubo, K., Gotoh, M., Fujieda, S., Okano, M., Yoshida, H., Morikawa, H., et al. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis. Allergol Int 57 (2008), 265–275.
4. 4 Uekusa, Y., Inamine, A., Yonekura, S., Horiguchi, S., Fujimura, T., Sakurai, D., et al. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study. Am J Rhinol Allergy 26 (2012), 92–96.
5. 5 Akdis, C.A., Blesken, T., Akdis, M., Wüthrich, B., Blaser, K., Role of interleukin 10 in specific immunotherapy. J Clin Invest 102 (1998), 98–106.
6. 6 Yamanaka, K., Yuta, A., Kakeda, M., Kitagawa, H., Ogihara, H., Gabazza, E.C., et al. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and monocytes∼IL-10 productivity is critical for becoming allergic∼. Allergol Int 60 (2011), 45–51.
7. 7 Yamanaka, K., Yuta, A., Kakeda, M., Sasaki, R., Kitagawa, H., Gabazza, E.C., et al. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis. J Allergy Clin Immunol 124 (2009), 842–845.
8. 8 Di Lorenzo, G., Mansueto, P., Pacor, M.L., Rizzo, M., Castello, F., Martinelli, N., et al. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol 123 (2009), 1103–1110.
9. 9 Fujimura, T., Yonekura, S., Horiguchi, S., Taniguchi, Y., Saito, A., Yasueda, H., et al. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin Immunol 139 (2011), 65–74.
10. 10 Okubo, K., Takizawa, R., Gotoh, M., Okuda, M., [Experience of specific immunotherapy with standardized Japanese cedar pollen extract]. Arerugi 50 (2001), 520–527 (in Japanese).
11. 11 Fujimura, T., Yonekura, S., Taniguchi, Y., Horiguchi, S., Saito, A., Yasueda, H., et al. The induced regulatory T cell level, defined as the proportion of IL-10(+)Foxp3(+) cells among CD25(+)CD4(+) leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy: a preliminary report. Int Arch Allergy Immunol 153 (2010), 378–387.
12. 12 Lou, W., Wang, C., Wang, Y., Han, D., Zhang, L., Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children. Pediatr Allergy Immunol 23 (2012), 140–149.
13. 13 van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Söllner, S., Akdis, D.G., et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131 (2013), 1204–1212.
14. 14 Carter, N.A., Vasconcellos, R., Rosser, E.C., Tulone, C., Muñoz-Suano, A., Kamanaka, M., et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186 (2011), 5569–5579.
15. + blood monocytes: their role in infection and inflammation. J Leukoc Biol 81 (2007), 584–592.
16. 16 Meiler, F., Zumkehr, J., Klunker, S., Rückert, B., Akdis, C.A., Akdis, M., In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205 (2008), 2887–2898.